Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pacgen Biopharmaceuticals, a life sciences company, has appointed Chung Wang, current chairman and director, as interim president and CEO of the company.
Subscribe to our email newsletter
Pacgen has also appointed Kevin McGarry, current director, as lead independent director of the board. These appointments follow the previously announced departure of Duffy DuFresne as president and CEO, effective immediately. Mr DuFresne also left the board of Pacgen.
The board of directors of Pacgen is now composed of Chung Wang, Kevin McGarry, Telvin Ju, Alan Moore and Hassan Salari. Mr Wang, one of the co-founders of Pacgen, has been chairman and director of the company since its incorporation in April 2004. Mr Wang currently serves as vice chairman of Tong Lung Metal Industry Co.
Mr Wang, said: “I am pleased to accept the role of interim president and CEO to facilitate the ongoing merger discussion with Medigen Biotechnology in Taiwan. We are thankful to Duffy for his contributions to Pacgen to date, and look forward to working with him in a different capacity as consultant to Pacgen.”